Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency

MONDO:0009946

Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency is a rare, hereditary, hemolytic anemia due to an erythrocyte nucleotide metabolism disorder characterized by mild to moderate hemolytic anemia associated with basophilic stippling and the accumulation of high concentrations of pyrimidine nucleotides within the erythrocyte. Patients present with variable features of jaundice, splenomegaly, hepatomegaly, gallstones, and sometimes require transfusions. Rare cases of mild development delay and learning difficulties are reported.

Also known as: P5N deficiency, UMPH1 deficiency, anemia, congenital, nonspherocytic hemolytic, 8, anemia, hemolytic, due to UMPH1 deficiency, hemolytic anemia due to P5N deficiency, hemolytic anemia due to UMPH1 deficiency, pyrimidine 5-prime nucleotidase deficiency, hemolytic anaemia due to, pyrimidine 5-prime nucleotidase deficiency, hemolytic anemia due to

23 clinical trials for this condition and its sub-types, 1 tagged with Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →
Sort by